Synthego

Synthego provides CRISPR genome engineering platform solutions from discovery to clinic, including synthetic sgRNA manufactured via proprietary methods for RUO, IND-enabling, and GMP grades compatible with nucleases like SpCas9, Cas12a, and MAD7. They offer cGMP CRISPR nucleases, high-performance IVT enzymes such as T7 RNA Polymerase and RNase Inhibitor, and molecular reagents for diagnostics, PCR, RNA synthesis, and CRISPR workflows. Synthego supports scalable gene editing with protein and mRNA formats and expanded manufacturing for cell and gene therapies.

Synthego is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include crispr sgrna, gmp grna, crispr nucleases, genome engineering, cell gene therapy.